Back to Health

What Is Abacavir and What Is It For?

What Is Abacavir and What Is It For?
Bareback Guide 8 January 2026

Abacavir is a nucleoside reverse transcriptase inhibitor used in combination HIV treatment. It has been in use since the late 1990s, is effective and well tolerated by most people, and carries one specific risk that makes a genetic test mandatory before the first dose.

What kind of drug is it?

A nucleoside analogue, from the oldest class of HIV medicines. These work by feeding the virus a defective building block, and abacavir is the guanosine version of that idea.

How does it work?

HIV carries its genome as RNA and must convert it into DNA using the reverse transcriptase enzyme before it can establish itself. Abacavir is converted inside the cell to an active form that closely resembles guanosine, one of the four natural DNA building blocks.

What happens when it is incorporated?

The enzyme takes it up as though it were the real thing and adds it to the growing DNA chain. Because it lacks the chemical attachment point the next building block requires, the chain cannot continue. Replication stops at that point and the viral DNA is never completed.

What is it used for?

HIV treatment only, always as part of a combination and never on its own. It is used both in people starting treatment and in people switching, most commonly within a single-tablet regimen.

Why is it never used alone?

Because HIV mutates rapidly and a single drug allows resistant virus to emerge within weeks. Modern treatment always uses at least two fully active drugs, which is why abacavir appears alongside lamivudine and usually a third agent.

Does it work against hepatitis B?

No, and this distinguishes it from tenofovir and lamivudine. It matters when choosing a regimen for anyone with both infections, since a combination based on abacavir would leave hepatitis B untreated. Hepatitis B status is checked before any regimen is chosen.

Why is a genetic test needed first?

Because a proportion of people carry a variant called HLA-B*5701, and those who do can develop a severe and potentially fatal hypersensitivity reaction to abacavir. Testing for it is routine, quick and mandatory, and anyone who carries it is simply not given the drug.

Does the test make it safe?

It removes almost all of the risk. Since routine screening was introduced, serious hypersensitivity has become uncommon. It has not disappeared entirely, so anyone starting it is told what to watch for in the first six weeks.

How does it compare with the alternatives?

It avoids the kidney and bone effects associated with tenofovir disoproxil, which is its main advantage. Against that, it requires the genetic test, does not cover hepatitis B, and has been the subject of a long-running debate about cardiovascular risk.

Where does it sit in current practice?

Still widely used, particularly within the single-tablet regimen combining it with lamivudine and dolutegravir. It is a reasonable first-line option for people who test negative for the gene variant and have no significant cardiovascular risk.

Is it available generically?

Yes. Abacavir and its common combinations have been available generically for some years, and generics must demonstrate the same absorption and blood levels as the original.

Where does it sit against the alternatives?

No antiretroviral is best in every situation. The fit depends on your genetic test result, your kidney function, your hepatitis status, your cardiovascular risk and your resistance history. That is a conversation with a clinician rather than a ranking.

How long has it been available?

Since the late 1990s, so there is more than twenty-five years of clinical experience with it. That length of record is itself worth something: the problems it has are known and quantified rather than still emerging.

What does it not do?

It treats HIV and nothing else. It has no effect on hepatitis B, no effect on any sexually transmitted infection, and no preventive role. Regular screening at every site remains necessary regardless of what you take.

Is it a lifelong medicine?

HIV treatment is taken indefinitely rather than for a course, because stopping allows the virus to rebound within weeks. What people take does change over the years, as better options appear and as circumstances shift, so being on abacavir now does not mean being on it forever.

Does it work if you take it properly?

For the great majority of people, yes. Modern combinations containing abacavir achieve an undetectable viral load in most people who take them consistently, and once suppression is sustained, HIV is not passed on sexually.